1月. 04, 2019

LEO Science & Tech Hub announce new collaboration to develop technology for minimally-invasive dermal biomarker assessment

LEO Science & Tech Hub today announced a two-year collaboration with the Karp Lab at Brigham and Women’s Hospital (BWH) to develop minimally-invasive technology to advance dermal biomarker assessment.

The Karp Lab, led by Jeffrey Karp, PhD, at BWH focuses on the development of platform technology and translational research to improve patient care. LEO Science & Tech Hub is an R&D innovation unit of LEO Pharma dedicated to identifying, developing, and funding innovative solutions that improve the lives of people with skin diseases.

LEO Science & Tech Hub and the Karp Lab will explore and develop technologies that could enable frequent and minimally-invasive assessment of relevant dermal biomarkers during clinical studies as well as the potential for diagnostic use in point-of-care testing. This kind of assessment could limit the number of painful skin biopsies patients must endure, and provide physicians with immediate feedback on how well a drug regimen is working.

Read more here.

News

5月. 2020 25 Innovative startups meet at EMERGENCE on April 9th, 2020

CEOs from cutting-edge life science startups share their real-life experience

詳しく読む
4月. 2020 02 EMERGENCE kicks off at Venture Café Tokyo on Feb 27, 2020

Experts discuss the future of the life science ecosystem in Japan from different perspectives

詳しく読む